Mathias Mathias

Mathias Uhlen is a Cu-Founder and serves as Chairman at Atlas Antibodies. He co-founded and served as Deputy Chairman and Scientific Advisor at Affibody. He serves as Board Member at Bure Equity. Dr. Uhln serves as Professor at Royal Institute of Technology. Dr. Uhln serves as a Board Member at SweTree Technologies and Affibody. Mathias Uhln is Professor of Microbiology at the Royal Institute of Technology, Stockholm, Sweden. Prof Uhln is member of the Royal Swedish Academy of Engineering Science (IVA) and he is also a member of the Royal Swedish Academy of Science. He also serves as Board Member at Bure Equity.